Literature DB >> 7939611

Bronchoalveolar lavage in the diagnosis of hard metal disease.

A Forni1.   

Abstract

Bronchoalveolar lavage (BAL) a technique which is not very invasive and which permits investigations of deep lung reactions from various causes, has been demonstrated to be also useful in the diagnosis of lung disorders from hard metals (HM) and/or cobalt, thus overcoming, in most cases, a need for open lung biopsies. Cases with HM interstitial disease show at BAL the signs of a high-intensity alveolitis, characterized by increased total cells with bizarre multinucleated giant cells and increased inflammatory cells. These findings correspond well to the histological pattern of desquamative giant cell interstitial pneumonitis. The persistence of alveolitis and especially high numbers of eosinophils at following BALs, despite cessation of exposure and steroid treatment, has an ominous prognostic significance. The few reported cases of cobalt asthma studied by BAL present either normal findings or increased T lymphocytes with inverted helper/suppressor ratio. This last finding has also been described in some asymptomatic exposed subjects, which indicates a subclinical (or preclinical?) lung reaction. Determination by neutron activation analysis of trace metals (cobalt, tungsten, tantalum) in BAL and other biological specimens may be important in documenting recent or past exposures, but is not discriminant for diagnosis, since no relationship has been found between levels of any metal and the occurrence of the disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7939611     DOI: 10.1016/0048-9697(94)90131-7

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  8 in total

Review 1.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

2.  Giant cell interstitial pneumonia associated with nitrofurantoin.

Authors:  Charles William Hargett; Thomas A Sporn; Victor L Roggli; John W Hollingsworth
Journal:  Lung       Date:  2006 May-Jun       Impact factor: 2.584

Review 3.  Inorganic dust pneumonias: the metal-related parenchymal disorders.

Authors:  P Kelleher; K Pacheco; L S Newman
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

4.  An observational study of giant cell interstitial pneumonia and lung fibrosis in hard metal lung disease.

Authors:  Junichi Tanaka; Hiroshi Moriyama; Masaki Terada; Toshinori Takada; Eiichi Suzuki; Ichiei Narita; Yoshinori Kawabata; Tetsuo Yamaguchi; Akira Hebisawa; Fumikazu Sakai; Hiroaki Arakawa
Journal:  BMJ Open       Date:  2014-03-27       Impact factor: 2.692

5.  Hard metal lung disease: a case series.

Authors:  Rafael Futoshi Mizutani; Mário Terra-Filho; Evelise Lima; Carolina Salim Gonçalves Freitas; Rodrigo Caruso Chate; Ronaldo Adib Kairalla; Regiani Carvalho-Oliveira; Ubiratan Paula Santos
Journal:  J Bras Pneumol       Date:  2016 Nov-Dec       Impact factor: 2.624

6.  Fast and Robust Proteome Screening Platform Identifies Neutrophil Extracellular Trap Formation in the Lung in Response to Cobalt Ferrite Nanoparticles.

Authors:  Anja M Billing; Kristina B Knudsen; Andrew J Chetwynd; Laura-Jayne A Ellis; Selina V Y Tang; Trine Berthing; Håkan Wallin; Iseult Lynch; Ulla Vogel; Frank Kjeldsen
Journal:  ACS Nano       Date:  2020-03-19       Impact factor: 15.881

7.  Two cases of hard metal lung disease showing gradual improvement in pulmonary function after avoiding dust exposure.

Authors:  Hiroya Terui; Satoshi Konno; Kichizo Kaga; Yoshihiro Matsuno; Kanako C Hatanaka; Hiromi Kanno; Hiroshi Moriyama; Motohiro Uo; Masaharu Nishimura
Journal:  J Occup Med Toxicol       Date:  2015-08-04       Impact factor: 2.646

Review 8.  Nanotoxicity: emerging concerns regarding nanomaterial safety and occupational hard metal (WC-Co) nanoparticle exposure.

Authors:  Andrea L Armstead; Bingyun Li
Journal:  Int J Nanomedicine       Date:  2016-12-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.